Skip to main content
Clinical Trials/NL-OMON26887
NL-OMON26887
Recruiting
Not Applicable

A feasibility study of the clinical effectiveness of Eye Movement Desensitization and Reprocessing as a second-step intervention for non-responders to Cognitive Behavioral Therapy for Panic Disorder with or without Agoraphobia”: an uncontrolled pilot study.

HSK, University of Utrecht0 sites15 target enrollmentTBD
ConditionsPanic disorder

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Panic disorder
Sponsor
HSK, University of Utrecht
Enrollment
15
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
HSK, University of Utrecht

Eligibility Criteria

Inclusion Criteria

  • 1\. a PD (with or without agoraphobia) as main classification according to DSM\-5 based on the SCID\-5\-S (APA, 2017\)
  • 2\. age above 18 years
  • 3\. sufficient mastery of Dutch to complete the questionnaires
  • 4\. less than 33\.33 % symptom reduction after nine treatment sessions of CBT
  • 5\. stable medication use (type and dosage) for at least four weeks and willingness of both patient and treating physician/psychiatrist to keep it stable during the study period
  • 6\. use of anxiolytic medication is allowed, even reduction in intake this medication to engage better in treatment attending any other psychological treatment during the study is not allowed.

Exclusion Criteria

  • 1\. very severe depression (QIDS\-C \= 20\)
  • 2\. acute suicidality
  • 3\. current Post Traumatic Stress Disorder (DSM\-5\)
  • 4\. severe alcohol or substance dependence (DSM\-5\)
  • 5\. lifetime psychotic disorder (DSM\-5\).

Outcomes

Primary Outcomes

Not specified

Similar Trials